The specific aims are to 1. determine the capacity of two inflammatory mediator molecules, interleukin-1 (IL-1) and platelet derived growth factor (PDGF), to alter synthesis of glycosaminoglycans (GAGs) and proteoglycans (PGs) in culture by fibroblasts derived from normal oral mucosa, oral mucosal wound granulation tissue, and mature oral mucosal scar tissues; 2. determine whether fibroblasts derived from wounded and non-wounded tissues are equally responsive to the designated mediators in terms of cellular proliferation and GAG/PG synthesis; and 3. determine if the GAGs or PGs whose synthesis is induced by mediator molecules subsequently exert direct influences on fibroblasts to perpetuate altered synthesis even after exposure to the mediator has ended. Excessive scarring of oral and perioral tissues results from altered matrix metabolism and is a major clinical problem since normal functioning of mucosal structures depends upon their pliability, resilience, barrier function, and absence of strictures; scarring impedes mastication, deglutition, nutrition, respiration, speech and appearance. Fibroblastic lines will be derived from biopsies of normal (uninjured) mucosa as well as from reparative tissues harvested at intervals from buccal mucosal wounds in New Zealand white rabbits. Type I cultures will be exposed to various concentrations of IL-1 or PDGF and then will be assayed for 1. rate of cellular proliferation, 2. GAG composition and synthetic rate and 3. PG protein core composition and synthetic rate. Selected cultures will be assayed for production of endogenous IL-1, endoglycosidases and proteinases. After mediator-induced alterations in GAG/PG production are known, the GAG/PG isolated from Type I cultures will be introduced to a second set of identical cultures (Type II) which have not been exposed previously to mediator molecules. Type II cultures will then be assayed to establish whether the GAG/PG whose synthesis is induced by mediators can exert direct influences on fibroblasts to perpetuate altered matrix synthesis in the absence of mediator.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE007803-03
Application #
3221578
Study Section
Oral Biology and Medicine Study Section (OBM)
Project Start
1986-08-01
Project End
1988-12-31
Budget Start
1988-08-01
Budget End
1988-12-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Bertolami, C N; Messadi, D V (1994) The role of proteoglycans in hard and soft tissue repair. Crit Rev Oral Biol Med 5:311-37
Bertolami, C N; Berg, S; Messadi, D V (1992) Binding and internalization of hyaluronate by human cutaneous fibroblasts. Matrix 12:11-21
Bertolami, C N; Bronson, R E (1990) Expression of different glycosaminoglycan synthetic phenotypes by lapine dermal and dermal wound fibroblasts. Matrix 10:1-9
Bronson, R E; Treat, J A; Bertolami, C N (1989) Fibroblastic subpopulations in uninjured and wounded rabbit oral mucosa. J Dent Res 68:51-8
Bronson, R E; Argenta, J G; Bertolami, C N (1988) Interleukin-1-induced changes in extracellular glycosaminoglycan composition of cutaneous scar-derived fibroblasts in culture. Coll Relat Res 8:199-208
Bertolami, C N; Ellis, D G; Donoff, R B (1988) Healing of cutaneous and mucosal wounds grafted with collagen-glycosaminoglycan/silastic bilayer membranes: a preliminary report. J Oral Maxillofac Surg 46:971-8
Bronson, R E; Argenta, J G; Siebert, E P et al. (1988) Distinctive fibroblastic subpopulations in skin and oral mucosa demonstrated by differences in glycosaminoglycan content. In Vitro Cell Dev Biol 24:1121-6
Ruggiero, S L; Bertolami, C N; Bronson, R E et al. (1987) Hyaluronidase activity of rabbit skin wound granulation tissue fibroblasts. J Dent Res 66:1283-7
Bronson, R E; Bertolami, C N; Siebert, E P (1987) Modulation of fibroblast growth and glycosaminoglycan synthesis by interleukin-1. Coll Relat Res 7:323-32